CJC-1295 (with DAC)

CJC-1295 with DAC

CJC-1295 with DAC is a synthetic peptide commonly studied in laboratory research involving growth hormone-releasing hormone signalling and downstream GH/IGF-1 response pathways.

Product Overview

CJC-1295 with DAC is a modified analogue of growth hormone-releasing hormone designed for extended activity in research settings. It is commonly examined in peptide and endocrine research for its interaction with GH pulse signalling and its downstream relationship with IGF-1 response. The DAC component is included to prolong activity, making this compound a continued area of interest in studies focused on long-acting peptide behaviour and hormone pathway investigation.

Common Research Interest Areas

• Growth hormone-releasing hormone pathway research
• GH and IGF-1 signalling studies
• Endocrine response modelling
• Long-acting peptide pharmacokinetic research

Product Specifications

• Compound: CJC-1295 with DAC
• Appearance: Lyophilised powder
• Available options: 2mg and 5mg
• Intended setting: Laboratory research use

Batch Verification & COA Access

Each vial is designed to support batch-level verification on arrival. Using the printed batch number and QR code, customers can access our Advanced COA Verification System to verify authenticity and review batch-specific certificate documentation where available.

Important Information

This product is supplied strictly for laboratory research purposes.

Not for human or veterinary use. For research use only.

No dosage, administration, or usage guidance will be provided, in line with our policy.

Product images are for illustrative purposes only. Packaging, vial appearance, powder volume, and batch presentation may vary slightly between production runs.